Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Tables)

v3.24.4
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Schedule of Potentially Dilutive Securities Excluded from Computation of Diluted Shares

The following potentially dilutive securities have been excluded from the computation of diluted shares of common stock outstanding as they would be anti-dilutive:

 

    2024     2023  
    September 30,  
    2024     2023  
Common stock warrants August 2021     14,031       16,039  
Underwriter warrants August 2021     284       284  
Chanticleer warrants     6       6  
Series C warrants     2,297       4,591  
Series 3 warrants     1,566       1,566  
Unvested restricted stock units and awards     17,152       288  
Common stock warrants February 2023     33,982       33,982  
Underwriter warrants February 2023     1,933       5,523  
Common stock private placement warrants June 2023     28,409       28,409  
Placement agent warrants June 2023     852       852  
Common stock warrants October 2023     354,994        
Underwriter warrants October 2023     10,664        
Placement agent warrants June 2024     14,142        
Common stock warrants June 2024     703,125        
Total anti-dilutive weighted average shares     1,183,437       91,540